FDA recall D-1172-2018

Mckesson Corporation · Class II · drug

Product

Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51

Reason for recall

Supterpotent Drug

Distribution

Nationwide within the United States

Key facts

Status
Terminated
Initiation date
2018-08-14
Report date
2018-09-12
Termination date
2020-11-25
Voluntary/Mandated
Voluntary: Firm initiated
Location
Memphis, TN, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1172-2018